Olumiant (Baricitinib) is a prescription medication used to treat moderate to severe rheumatoid arthritis (RA), alopecia areata, and certain hospitalized COVID-19 cases. As a Janus kinase (JAK) inhibitor, it helps reduce inflammation and modulate the immune response. Available in 2mg tablets, Olumiant offers a convenient oral treatment option for eligible patients.​
Precautions of Olumiant Tablet:
- Infections: Baricitinib can increase the risk of serious infections. Test for latent tuberculosis before initiating therapy.
- Blood Clots: There is an increased risk of deep vein thrombosis and pulmonary embolism. Monitor patients for signs of thrombosis.
- Cancer Risk: An increased risk of certain cancers has been observed. Regular monitoring is recommended.
- Liver and Kidney Function: Adjust dosage in patients with moderate renal impairment; not recommended for severe renal impairment.
Uses of Olumiant Tablet:
| Condition | Description |
| Rheumatoid Arthritis (RA) | For adults with moderately to severely active RA who have had an inadequate response to one or more tumor necrosis factor (TNF) antagonist therapies. |
| Alopecia Areata | Approved for adults with severe alopecia areata, an autoimmune disorder causing hair loss. |
| COVID-19 (Hospitalized Adults) | Authorized for use in hospitalized adults requiring supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ECMO). |
Side Effects of Olumiant Tablet:
| Severity | Side Effects |
| Common | Upper respiratory tract infections, nausea, increased liver enzymes, cold sores, shingles. |
| Serious | Serious infections (e.g., tuberculosis), increased risk of death, cancer, major cardiovascular events, blood clots. |
FAQs of Olumiant Tablet:
1. How should I take Olumiant?
Take Olumiant exactly as prescribed by your healthcare provider, usually once daily with or without food.​
2. Can I take Olumiant if I have an infection?
Inform your doctor about any infections before starting Olumiant. It may increase the risk of serious infections.​
3. Is Olumiant safe during pregnancy?
The safety of Olumiant during pregnancy is not established. Consult your doctor for advice.
Interactions of Olumiant Tablet:
| Interacting Agent | Recommendation |
| Strong OAT3 Inhibitors (e.g., probenecid) | Reduce baricitinib dose to 1 mg/day. |
| Live Vaccines | Avoid use during treatment due to immunosuppressive effects. |
| Other JAK Inhibitors or Biologic DMARDs | Not recommended to use concurrently. |
| Manufacturer | : | Eli Lilly And Company |
| Trade Name | : | |
| Generic Search | : | |
| Strength | : | 2MG, 4MG |
Latest Products
